Faye Feller - 09 Jul 2022 Form 3 Insider Report for GERON CORP (GERN)

Role
EVP, Chief Medical Officer
Signature
/s/ Olivia Bloom for Faye Feller
Issuer symbol
GERN
Transactions as of
09 Jul 2022
Net transactions value
$0
Form type
3
Filing time
12 Jul 2022, 11:49:44 UTC
Previous filing
12 Jul 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GERN Stock Options (right to buy) 09 Jul 2022 Common Stock 400,000 $1.74 Direct F1
holding GERN Stock Options (right to buy) 09 Jul 2022 Common Stock 80,000 $1.74 Direct F2
holding GERN Stock Options (right to buy) 09 Jul 2022 Common Stock 155,400 $1.30 Direct F3
holding GERN Stock Options (right to buy) 09 Jul 2022 Common Stock 155,400 $2.06 Direct F4
holding GERN Stock Options (right to buy) 09 Jul 2022 Common Stock 200,000 $1.06 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests as follows: 50,000 shares on October 8, 2019, the remaining 350,000 shares in a series of 42 equal monthly installments commencing October 8, 2019, provided the optionee continues to provide services to the Company.
F2 This option vests in 3 years on April 8, 2022, provided the optionee continues to provide services to the Company.
F3 This option vests in a series of 48 consecutive equal monthly installments commencing on February 12, 2020, provided the optionee continues to provide services to the Company.
F4 This option vests in a series of 48 consecutive equal monthly installments commencing on February 2, 2021, provided the optionee continues to provide services to the Company.
F5 This option vests in a series of 48 consecutive equal monthly installments commencing on February 16, 2022, provided the optionee continues to provide services to the Company.